SHE:002365 Revenue

In the year 2025, Qianjiang Yongan Pharmaceutical had annual revenue of 783.17M CNY, down -6.63%. Qianjiang Yongan Pharmaceutical had revenue of 206.02M in the quarter ending December 31, 2025, a decrease of -6.40%.

Revenue

783.17M

Revenue Growth

-6.63%

P/S Ratio

5.06

Revenue / Employee

842.12K

Employees

930

Market Cap

3.96B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	783.17M	-55.65M	-6.63%
Dec 31, 2024	838.81M	-134.08M	-13.78%
Dec 31, 2023	972.89M	-489.56M	-33.48%
Jan 1, 2023	1.46B	-102.96M	-6.58%
Jan 1, 2022	1.57B	392.56M	33.47%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Henan Taloph Pharmaceutical Stock Co.,Ltd	1.76B
Nanjing Well Pharmaceutical Group	1.34B
Huaren Pharmaceutical	1.33B
PKU HealthCare Corp.,Ltd.	1.20B
Hunan Hansen Pharmaceutical	1.05B
Harbin Medisan Pharmaceutical	813.23M
Zhejiang Cheng Yi Pharmaceutical	790.86M
Tibet AIM Pharm.	670.32M

Revenue Rankings